Carboplatin, Paclitaxel With or Without Avelumab in Advanced or Recurrent Endometrial Cancer
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Endometrial Cancer
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Phase 2 randomized with a safety run-in cohort for the experimental armMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 125 years
- Gender
- Only males
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT03503786
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Sandro Pignata, M.D., Ph.D. National Cancer Institute, Naples Principal Investigator: Francesco Perrone, M.D., Ph.D. National Cancer Institute, Naples Principal Investigator: Gennaro Daniele, M.D., Ph.D. National Cancer Institute, Naples Principal Investigator: Ciro Gallo, M.D. University of Campania "Luigi Vanvitelli"
Get Well Soon